These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4146789)

  • 21. Studies of 1-(o-cyclopropylphenoxy)-3-isopropylamino-2-propanol, a new -adrenergic blocking drug.
    Boissier JR; Giudicelli JF; Viars P; Advenier C; Mouille P; Larno S
    Eur J Pharmacol; 1971 Jul; 15(2):151-9. PubMed ID: 4403548
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacological studies with tiprenolol and propranolol in man.
    Kesteloot H; Sluyts R; Floor-Wieringa A; van Strik R
    Eur J Pharmacol; 1973 Mar; 21(3):257-63. PubMed ID: 4145318
    [No Abstract]   [Full Text] [Related]  

  • 23. [Beta adrenolytic activity and hemodynamic effects of penbutolol].
    Boissier JR; Coutte R; Advenier C; Giudicelli JF
    Therapie; 1973; 28(6):1251-65. PubMed ID: 4152643
    [No Abstract]   [Full Text] [Related]  

  • 24. [Selective beta-blocking action of practolol (ICI 50.172)].
    Novelli GP; Pagni E; Cortesini C; Pagliai P; Francini R
    Minerva Anestesiol; 1969 Dec; 35(12):1286-94. PubMed ID: 4394406
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacological studies on 1-(7-indenyloxy)-3-isopropylaminopropan-2-Ol hydrochloride (YB-2), a new -adrenergic blocking agent.
    Tachikawa S; Takenaka T
    Arch Int Pharmacodyn Ther; 1973 Mar; 202(1):79-92. PubMed ID: 4144371
    [No Abstract]   [Full Text] [Related]  

  • 26. Haemodynamic effects of selective beta-adrenergic blockade during acute stage of myocardial infarction.
    Epois A; Rocha P; Roudy G; Bardet J; Bourdarias JP; Mathivat A
    Br Heart J; 1972 Dec; 34(12):1295-301. PubMed ID: 4405235
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on the nature of the bronchial -adrenoreceptors.
    Boissier JR; Advenier C; Giudicelli JF; Viars P
    Eur J Pharmacol; 1971 Jun; 15(1):101-9. PubMed ID: 4143978
    [No Abstract]   [Full Text] [Related]  

  • 28. Trasicor: review of the pharmacology and clinical results.
    Fuccella LM
    S Afr Med J; 1969 Dec; ():Suppl:7-14. PubMed ID: 4190429
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of propranolol, practolol, trasicor and visken on cardiac chronotropism and supraventricular or ventricular arrhythmias].
    Goch JH
    Pol Tyg Lek; 1972 Dec; 27(52):2049-51. PubMed ID: 4405621
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of cardioselective beta adrenergic blockaders in the treatment of circulatory failure].
    Sterkowicz S
    Pol Tyg Lek; 1973 Jun; 28(26):987-90. PubMed ID: 4146971
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics of M&B 17,803A in animals and man.
    Basil B; Collins RF; Cuthbert MF
    Br J Pharmacol; 1973 Mar; 47(3):620P. PubMed ID: 4147192
    [No Abstract]   [Full Text] [Related]  

  • 32. [Action of various beta adrenolytic agents on the alpha blocking properties of yohimbine in the dog].
    Mouillé P; Cheymol G
    C R Seances Soc Biol Fil; 1973; 167(3):440-2. PubMed ID: 4150410
    [No Abstract]   [Full Text] [Related]  

  • 33. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K; Kubota M; Odashiro M; Yasuda K; Goto Y
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hemodynamic changes following blockade of the beta-receptors in healthy persons and in patients with coronary heart disease. Comparison between Trasicor and Inderal].
    Bürgin D
    Schweiz Med Wochenschr; 1968 Jun; 98(25):940-5. PubMed ID: 5699197
    [No Abstract]   [Full Text] [Related]  

  • 35. [Circulatory effects of a new specific beta adrenergic blocking agent, (o-(2-hydroxy-3-(tert. butylamino)-propoxyl)-benzonitrile, Kö 1366)].
    Gilfrich HJ; Rahn KH; Nicolescu RF
    Arzneimittelforschung; 1973 Jun; 23(6):768-71. PubMed ID: 4146902
    [No Abstract]   [Full Text] [Related]  

  • 36. Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal.
    Wasserman AJ; Proctor JD; Allen FJ; Kemp VE
    J Clin Pharmacol J New Drugs; 1970; 10(1):37-49. PubMed ID: 4391785
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of beta sympatholytic agent ICI 50172 (Dalzic) in various cardiovascular diseases].
    Müller H; Barthels F; Kluthe R
    Med Klin; 1973 May; 68(19):634-41. PubMed ID: 4125216
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of propranolol, oxprenolol, and practolol on denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br Heart J; 1971 Jul; 33(4):614-5. PubMed ID: 4397631
    [No Abstract]   [Full Text] [Related]  

  • 39. -adrenergic blocking and cardiovascular properties of a new compound, 1-(7-indenyloxy)-3-isopropylaminopropan-2-ol-hydrochloride (YB-2).
    Tanenaka T; Tachikawa S
    Arzneimittelforschung; 1972 Nov; 22(11):1864-9. PubMed ID: 4144713
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
    Brunner H; Hedwall PR; Meier M
    Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.